小児不完全骨発症における血清オステオカルシン: 疾患の種類とビスホスフォナート療法の影響
Jakub Krzysztof Nowicki1, Elżbieta Jakubowska-Pietkiewicz1
1Department of Pediatrics, Neonatal Pathology and Metabolic Bone Diseases, Medical University of Lodz, Sporna 36/50, 91-738 Lodz, Poland.
International journal of molecular sciences
|August 28, 2025
まとめ
オステオゲネシス・インパーフェクト (OI) の小児では血清オステオカルシン濃度が上昇しています. 3型OIとパミドロナート治療は,骨形成の重要なマーカーであるオステオカルシンを減少させます.
科学分野:
- 小児内分泌学
- 骨の代謝
- 遺伝 的 な 疾患
背景:
- オステオゲネシス・インパーフェクト (OI) は骨の脆弱性による遺伝疾患のグループです.
- 血清オステオカルシンは骨形成のマーカーですが,ビスホスフォナート治療を受けている小児OI患者におけるその行動は完全に理解されていません.
研究 の 目的:
- 静脈注入パミドロナートで治療されたOIの小児における血清オステオカルシン濃度に影響を与える要因を調査する.
- 小児OIの管理におけるオステオカルシン評価の役割を決定する.
主な方法:
- OIタイプ1または3の61人の小児患者 (年齢2〜18歳) の遡及分析.
- 収集されたデータには,人口統計,骨折歴,血清オステオカルシン,アルカリリンフォスファタゼ,25 ((OH)) D3,クレアチニン,DXA BMDのzスコアが含まれていました.
- オステオカルシン濃度とOI型,パミドロナート治療,その他の臨床的要因との関係を分析した.
主要な成果:
- 年齢と性別を合わせた基準と比較して,OI患者ではオステオカルシン濃度が高かった.
- OIタイプ3の患者は,OIタイプ1よりもオステオカルシンが有意に低かった.
- パミドロナート治療の頻度の増加は,オステオカルシン濃度の低下と相関していた.
- OI型はオステオカルシン濃度の最も強い予測因子で,骨質量と骨折の頻度は関係しなかった.
結論:
- 小児のOIではオステオカルシンが上昇するが,パミドロナート療法では減少する.
- OI型はオステオカルシン濃度の重要な決定因子です.
- 小児のOIに対するビスフォスフォナート治療の開始時にオステオカルシン測定は価値があります.
関連する概念動画
Bone Disorders
3.9K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.9K
Hormones and Bone Tissue
2.9K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.9K
Osteoclasts in Bone Remodeling
3.2K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.2K
What is the Skeletal System?
53.6K
Overview
53.6K
Bone Remodeling
38.5K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.5K
Role of Vitamins in Maintaining Bone Health
3.6K
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
3.6K


